Pro Share Advisors LLC Rapt Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$17.02 - $40.22 $150,048 - $354,579	-8,816 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$29.5 - $39.5 $6,401 - $8,571	-217 Reduced 2.4%	8,816 $324,000
Q3 2021 Nov 12, 2021	SELL	$29.86 - $39.47 $3,702 - $4,894	-124 Reduced 1.35%	9,033 $280,000
Q2 2021 Aug 13, 2021	BUY	$17.99 - $40.02 $164,734 - $366,463	9,157 New	9,157 $291,000

104

27.1M

26.7K

2.4K

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $32M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.